CYBIN INC. — Investor Relations & Filings
Cybin Inc. is a late-stage clinical neuropsychiatry company dedicated to revolutionizing mental healthcare by developing novel psychedelic-based therapeutics. The company utilizes proprietary drug discovery platforms, innovative drug delivery systems, and a deuterated chemical process to engineer next-generation, patent-protected drug candidates from tryptamine-based scaffolds. Its lead programs include CYB003, a deuterated psilocybin analog for Major Depressive Disorder (MDD) that has received FDA Breakthrough Therapy Designation, and CYB004 for the treatment of Generalized Anxiety Disorder (GAD). Cybin aims to create safer, more effective, and commercially scalable treatments for various mental health conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-28 | English | |
| 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-23 | English | |
| 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-20 | English | |
| 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-20 | English | |
| 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-16 | English | |
| 6-K Filing | 2026-02-18 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 38139607 | 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-28 | English | ||
| 35894872 | 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-23 | English | ||
| 34694400 | 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-20 | English | ||
| 34693984 | 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-20 | English | ||
| 34648069 | 6-K - CYBIN INC. (0001833141) (Filer) | 2026-04-16 | English | ||
| 31978132 | 6-K Filing | 2026-02-18 | English | ||
| 31978135 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31978134 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 31978131 | 6-K Filing | 2026-02-17 | English | ||
| 31978136 | 6-K Filing | 2026-02-13 | English | ||
| 31978133 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 31978137 | 6-K Filing | 2026-02-10 | English | ||
| 13343163 | Regulatory Filings 2026 | 2026-01-12 | English | ||
| 13343166 | 6-K | 2026-01-05 | English | ||
| 13343164 | Regulatory Filings 2026 | 2026-01-02 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ArriVent BioPharma, Inc.
Clinical-stage biopharma developing oncology drugs for diff…
|
AVBP | US | Manufacturing |
|
ARROWHEAD PHARMACEUTICALS, INC.
Biotechnology company developing RNAi therapies to treat in…
|
ARWR | US | Manufacturing |
|
ARS Pharmaceuticals, Inc.
Develops and commercializes needle-free products for admini…
|
SPRY | US | Manufacturing |
|
ARTELO BIOSCIENCES, INC.
Clinical-stage biopharma developing therapeutics by modulat…
|
ARTL | US | Manufacturing |
|
Arura Pharma Inc
Diversified manufacturer and distributor in consumer goods …
|
— | CA | Manufacturing |
|
Ascelia Pharma
Biotechnology company developing and commercializing novel …
|
ACE | SE | Manufacturing |
|
Ascendis Pharma A/S
Biopharmaceutical firm using its prodrug technology to trea…
|
ASND | DK | Manufacturing |
|
Ascentage Pharma Group International
Integrated biopharma developing novel small molecule therap…
|
6855 | HK | Manufacturing |
|
ASCENTAGE PHARMA GROUP INTERNATIONAL
A clinical-stage biopharma developing novel therapies for c…
|
AAPG | US | Manufacturing |
|
Ascletis Pharma Inc.
R&D driven biotech developing best-in-class therapeutics, p…
|
1672 | KY | Manufacturing |
CYBIN INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33911/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33911 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33911 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33911 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33911}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CYBIN INC. (id: 33911)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.